Support efforts to clarify Medicare authority regarding local coverage determinations.
Support HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016.
Support efforts to extend the medical device tax suspension.
General support for 21st Century Cures.
Duration: June 1, 2007
to
December 31, 2016
General Issues: Medicare/Medicaid , Taxation/Internal Revenue Code , Health Issues , Transportation , Trade (Domestic & Foreign) , Copyright/Patent/Trademark , Law Enforcement/Crime/Criminal Justice , Natural Resources , Labor Issues/Antitrust/Workplace , Budget/Appropriations , Agriculture , Foreign Relations , Manufacturing , Medical/Disease Research/Clinical Labs
Spending: about $5,830,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), House of Representatives,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2016
St. Jude Medical, Inc. in-house lobbying effort was terminated on Jan. 23, 2017
Original Filing: 300857442.xml
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations.
Support HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Support efforts to extend the medical device tax suspension.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
General support for 21st Century Cures.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 3, 2017.
Original Filing: 300843503.xml
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Support efforts to extend the medical device tax suspension.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
General support for 21st Century Cures.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 3, 2017.
Original Filing: 300843504.xml
Lobbying Issues
General support for 21st Century Cures.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 20, 2016.
Original Filing: 300821920.xml
Lobbying Issues
General support for Senate Counterpart to HR 6, 21st Century Cures
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
FAA reauthorization bill - oppose additional lithium ion battery shipping restrictions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 20, 2016.
Original Filing: 300803683.xml
Lobbying Issues
General support for Senate Counterpart to HR 6, 21st Century Cures
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
FAA reauthorization bill - oppose additional lithium ion battery shipping restrictions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 26, 2016.
Original Filing: 300785341.xml
Lobbying Issues
General support for HR 6, 21st Century Cures
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support legislation to repeal the medical device tax HR 160/ S 149
Support the PATH Act - tax Extender Package and medical device tax suspension
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2015
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Nov. 17, 2015.
Original Filing: 300767667.xml
Lobbying Issues
General support for HR 6, 21st Century Cures
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support legislation to repeal the medical device tax
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support efforts to clarify Medicare authority regarding local coverage determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2015
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Sept. 16, 2015.
Original Filing: 300750100.xml
Lobbying Issues
Issues related to HR 6, 21st Century Cures
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support changes to New Technology Add-on Payment program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Support legislation to repeal the medical device tax
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2015
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 20, 2015.
Original Filing: 300727750.xml
Lobbying Issues
Issues related to 21st Century Cures legislative draft
Issues related to regulation of healthcare related software
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
General support for Trade Promotion Authority and Trans-Pacific Partnership
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Support legislation to repeal the medical device tax
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2014
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on March 12, 2015.
Original Filing: 300711664.xml
Lobbying Issues
Support efforts to repeal the medical device tax - support - H.R. 523/S. 232
Support R&D Tax credit extension
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2014
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300689183.xml
Lobbying Issues
HR 523 - Protect Medical Innovation Act/S.232 Medical Device Access and Innovation Act - Support repeal of the medical device tax
General support for renewing research and development tax credit
General support comprehensive tax reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Implemtation of the Food Drug Safety and Innovation Act (FDAISA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300668811.xml
Lobbying Issues
HR 523 - Protect Medical Innovation Act/S.232 Medical Device Access and Innovation Act - Support repeal of the medical device tax
General support for renewing research and development tax credit
General support comprehensive tax reform
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support Medicare New Technology Add-On Payment Application
Agencies Lobbied
Food & Drug Administration (FDA)
Lobbying Issues
General support for Trade Promotion Authority and the Trans Pacific Partnership Agreement
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2014
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 21, 2014.
Original Filing: 300647046.xml
Lobbying Issues
HR 523/S. 232 Support repeal of the medical device tax
Support reinstating R&D tax credit
Support territorial tax reform proposals
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support Trade Promotion Authority (TPA) for trade agreements.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Support trade secret theft draft proposals
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2013
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 24, 2014.
Original Filing: 300629070.xml
Lobbying Issues
Support repeal of the medical device tax HR 523/S. 232
Support R&D Tax credit extension
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support H.R. 2725, the FDA SOS Act legislation proposing to permanently exempt FDA user fees from sequestration and related legislation to release existing sequestered fees.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Protecting American Trade Secrets and Innovation Act of 2013
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2013
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Nov. 19, 2013.
Original Filing: 300609959.xml
Lobbying Issues
Issues related to R&D tax credit and corporate/international tax proposals
Support repeal of medical device excise tax
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support reauthorization of bureau of land management national helium reserves program
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2013
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Nov. 19, 2013.
Original Filing: 300609951.xml
Lobbying Issues
Issues related to R&D tax rredit and corporate/international tax proposals
Support repeal of medical device excise tax
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support reauthorization of bureau of land management national helium reserves program
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on May 10, 2013.
Original Filing: 300567188.xml
Lobbying Issues
Support legislation to repeal the medical device excise tax, specifically HR 523, The Protect Medical Innovation Act. General support for corporate tax reform, including hybrid territorial tax reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
General implementation issues with the Affordable Care Act: ACO's, physician disclosure
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support The Responsible Helium Administration and Stewardship Act (H.R. 527) to allow the Bureau of Land Management to sell helium from the Federal Helium Reserve.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2012
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300541866.xml
Lobbying Issues
Support legislation to repeal the medical device excise tax, specifically hr 436, The Protect Medical Innovation Act. General support for corporate tax reform, including hybrid territorial tax reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
General implementation issues with the Affordable Care Act: ACO's, physician disclosure, PCORI.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Oct. 22, 2012.
Original Filing: 300520368.xml
Lobbying Issues
Support legislation to repeal the medical device excise tax, specifically hr 436, The Protect Medical Innovation Act. General support for corporate tax reform, including hybrid territorial tax reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
General implementation issues with the Affordable Care Act: ACO's, physician disclosure, PCORI.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 20, 2012.
Original Filing: 300499428.xml
Lobbying Issues
Support for legislation to repeal the medical device excise tax: S.17 The Medical Device Access and
Innovation Protection Act, S.262 A bill to repeal the excise tax on medical device manufacturers,H.R. 436 The Protect
Medical Innovation Act, H.R. 734 To amend the Internal Revenue Code of 1986 to repeal the medical device tax
Support corporate tax reform, including hybrid territorial tax reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Support for regulatory reforms in conjunction with Food and Drug Administration Safety and Innovation Act (S.3187). General Implementation issues with the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Education regarding Office of Federal Contract Compliance Programs (OFCCP) proposed regulations on Section 503 of the Rehabilitation Act of 1973.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2012
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 24, 2012.
Original Filing: 300476472.xml
Lobbying Issues
Affordable Care Act implementation issues regarding ACO's
General support for the reauthorization of the medical device user fee modernization act.
General support for FDA regulatory reforms in conjucntion with the medical device user fee reauthorization.
H.R. 3209 The Premarket Predictability Act, H.R. 3203 Novel Device Regulatory Relief Act of 2011, H.R. 3230 Keeping America Competitive through Harmonization Act, H.R. 3211 Humanitarian Device Reform Act of 2011, H.R. 3208 Patients Come First Act, H.R. 3206 Cultivating Scientific Expertise to Foster Innovation Act, H.R. 3214 Food and Drug Administration Mission Reform Act, H.R. 3204 Guidance Accountability and Transparency Act, H.R. 3205 FDA Renewing Efficiency from Outside Review Management Act of 201, S.1700 The Medical Device Regulatory Improvement Act, S 1865Patient Access to Medical Innovation Act, Discussion drafts regarding medicial device user fee reauthoiization from the House Energy and Commerce Committee and the Senate.Health, Education, Labor and Pensions Committee
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
General support or legislation to repeal the medical device excise tax: S.17 The Medical Device Access and Innovation Protection Act, S.262 A bill to repeal the excise tax on medical device manufacturers,H.R. 436 The Protect Medical Innovation Act, H.R. 734 To amend the Internal Revenue Code of 1986 to repeal the medical device tax
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2011
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300453310.xml
Lobbying Issues
Support FDA regulatory process reform, MDUFMA reauthorization negotiations, IDE and HDE process reforms.
Support: H.R. 3209 Premarket Predictability Act, H.R. 3203 Novel Device Regulatory Relief Act, H.R. 3205 FDA Renewing Efficiency from Outside Review Management Act, H.R. 3211 Humanitarian Device Reform Act, H.R. 3208 Patients Come First Act, H.R. 3206 Cultivating Scientific Experts to Foster Innovation Act, H.R. 3214 Food and Drug Administration Mission Reform Act,H.R. 3204 Guidance Accountability and Transparency Act, S. 1700 The Medical Device Regulatory Improvement Act, S. 1865 The Patient Access to Medical Innovation Act, S. 1943 Novel Device Regulatory Relief Act of 2011
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Oppose cuts to the Graduate Medical Education (GME) and Indirect Medical Expense (IME) programs funded through Medicare in discussion drafts of the Joint Select Committee on Deficit Reduction.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
International tax issues regarding intangible and territorial tax reform. Corporate tax reform. Support S. 17/HR 436 repeal of medical device tax. Support extension of R&D tax credit.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2011
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Oct. 21, 2011.
Original Filing: 300430112.xml
Lobbying Issues
FDA 510(k) regulatory process reform. MDUFMA reauthorization negotiations, IDE and HDE process reforms.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
International tax issues regarding intangibles and territorial tax reform. Corporate tax reform. S.17/HR 436: Support repeal of Medical Device Tax.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2011
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 20, 2011.
Original Filing: 300406157.xml
Lobbying Issues
FDA 510(k) regulatory process reform. MDUFMA reauthorization negotiations, IDE and HDE process reforms.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
International tax issues regarding intangibles and territorial tax reform. Corporate tax reform. S.17/HR 436: Support repeal of Medical Device Tax.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2011
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 21, 2011.
Original Filing: 300380960.xml
Lobbying Issues
FDA 510(k) regulatory process reform. MDUFMA reauthorization negotiations.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4016 Hazmat Bill: changes to regulations regarding transportation of lithium ion batteries.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
International tax issues regarding intangibles and territorial tax reform. S.17/HR 436: Support repeal of Medical Device Tax.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2011.
Original Filing: 300345692.xml
Lobbying Issues
FDA 510(k) regulatory process reform. FDA tissue importation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4016 Hazmat Bill: changes to regulations regarding transportation of lithium ion batteries.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4213/S 1203 Tax Extenders Legislation: support the renewal of the R&D Tax Credit. International tax issues regarding intangibles and territorial tax.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2010
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2010.
Original Filing: 300317272.xml
Lobbying Issues
HR 3590/4872: healthcare reform legislation: provisions related to medical device tax, physician sunshine act, medical device registry, comparative effectiveness research, independent medicare adviosry board, national pain care act. HR 1346/S 540 Medical Device Safety Act - oppose removal of federal preemption. 510(k) regulatory process reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4016 Hazmat Bill: changes to regulations regarding transportation of lithium ion batteries.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4213/S 1203 Tax Extenders Legislation: support the renewal of the R&D Tax Credit. International tax issues regarding intangibles and territorial tax.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2010
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300301845.xml
Lobbying Issues
HR 3590/4872: healthcare reform legislation and reconciliation: provisions related to medical device tax, physician sunshine act, medical device registry, comparative effectiveness research, independent Medicare advisory board, national pain care act.
HR 1346/S 540 Medical Device Safety Act: oppose removal of federal preemption.
HR 4700/HR 2249/HR 4803 Health Care Pricing Transparency. Potential 510(k) regulatory process reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4016 Hazmat Bill: changes to regulations regarding transportation of lithium ion batteries.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4213/S 1203 Tax Extenders Legislation: support the renewal of the R&D Tax Credit.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300267563.xml
Lobbying Issues
HR 3590/HR 3962: healthcare reform legislation: provisions related to medical device tax, physician sunshine act, medical device registry, comparative effectiveness research, independent medicare adviosry board, natpain care management.
HR 1346/S 540 Medical Device Safety Act - oppose removal of federal preemption.
510(k) regulatory process reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4016 Hazmat Bill: changes to regulations regarding transportation of lithium ion batteries.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4213/S 1203 Tax Extenders Legislation: support the renewal of the R&D Tax Credit.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300242682.xml
Lobbying Issues
HR 3200, HR 3962, Reid Substitute - amendment to HR 3590: healthcare reform legislation: provisions related to medical device tax, physician sunshine, medical device registry, comparative effectiveness research, independent medicare advisory board.
HR 756/S 660 National Pain Care Act - support legislation to improve pain care research, education, access, outreach and care.
HR 1346/S 540 Medical Device Safety Act - oppose removal of federal preemption.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 4016 Hazmat Bill: provision regarding transport of lithium ion batteries.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
HR 4213/S 1203 Tax extenders legislation: suport renewal of R&D Tax credit
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Oct. 16, 2009.
Original Filing: 300224085.xml
Lobbying Issues
H.R. 3200 -medical device registry, continued funding for gainsharing, physician sunshine
S 540/HR1346 - Medical Device Safety Act
America's Healthy Future Act of 2009 - medical device fee, physician sunshine, independent medicare commission
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300193989.xml
Lobbying Issues
S. 540/HR 1346 Medical Device Safety Act - oppose removal of federal preemption
S.660/HR 756 National Pain Care Policy Act - support
healthcare reform bills/proposals-physician gift disclosure, comparative effectiveness research, gainsharing
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 301Physician Payments Sunshine Act of 2009 - support
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1409/S.560 Employee Free Choice Act - oppose
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Support Highway 36/ Rice St. bridge reconstruction project
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300165329.xml
Lobbying Issues
S. 540/HR 1346 Medical Device Safety Act - oppose removal of federal preemption
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1 The American Rcovery and Reinvestment Act - support comparative clinical effectiveness
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1409/S.560 Employee Free Choice Act - oppose
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2008
In Q4, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Jan. 16, 2009.
Original Filing: 300125787.xml
Lobbying Issues
HR 6381/S. 3398 - Medical Device Safety Amendments Act - oppose removal of federal preemption
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Support S. 2029, Physician Payments Sunshine Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on Oct. 8, 2008.
Original Filing: 300099025.xml
Lobbying Issues
HR 6331 - Medicare Improvements for Patiens and Providers Act of 2008:
Support physician payment update
Support inclusion of H.R. 5765, Medicare Remote Monitoring Access
Support inclusion of S. 2029, Physician Payments Sunshine Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 2138/S.2209 Investment in America Act - support extension of the R&D tax credit
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 6381/S. 3398 - Medical Device Safety Amendments Act - oppose removal of federal preemption
H.Con.Res 393/Sen. Con Res. 93 - Support National Sudden Cardiac Awareness Month
FDA Globalization Act - support appropriate inspections process for medical devices
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300082934.xml
Lobbying Issues
H.R. 6331- Medicare Improvements for Patients and Providers Act of 2008:
Support physcian payment update
Support inclusion of H.R. 5765, Medicare Remote Monitoring Access Act (S. 631)
Support inclusion of S. 2029, Physician Payments Sunsine Act (H.R. 5605)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 2138/S. 2209 Investment in America Act - support extension of the R&D Tax credit
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Medical Device Safety Amendments Act - preserve current FDA law, oppose removal of federal preemption
FDA Globalization Act - support appropriate inspections process for medical devices
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 1145 Patent Reform Act - oppose sec. 11 applicant quality submission requirements
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2008
St. Jude Medical, Inc. filed a lobbying registration on July 7, 2008 for in-house lobbying efforts, effective June 1, 2008.
Original Filing: 300082921.xml
Issue(s) they said they’d lobby about: Any legislation affecting medical device manufacturing or medical technology; specifically Medicare policy affecting reimbursement rates for medical devices and clinical trial policy .
1st Quarter, 2008
St. Jude Medical, Inc. amended a lobbying report for in-house lobbying in Q12008 on July 21, 2008
Original Filing: 300082931.xml
Lobbying Issues
S. 1145 the Patent Reform Act: Oppose Section 11 - Applicant Quality Submissions.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
S. 2029 Physician Sunshine Act - support legislation with modifications (eliminate reporting threshold, preemption)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 2419/S.2302 Farm Bill - provision related to physicians and reps being able to train on live animals
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2138/S. 2209 Support R&D tax credit extension
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2008
In Q1, St. Jude Medical, Inc. had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300047743.xml
Lobbying Issues
S. 1145 the Patent Reform Act: Oppose Section 11 - Applicant Quality Submissions.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
S. 2029 Physician Payments Sunshine Act - support legislation with modifications (eliminate reporting threshold, preemption)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2419/S.2302 Farm Bill - provision related to physicians and reps being able to train on live animals
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2138/S.2209 - Support R&D tax credit extension
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2007
St. Jude Medical., Inc. filed a lobbying registration on Jan. 8, 2008 for in-house lobbying efforts, effective June 1, 2007.
Original Filing: 300004728.xml
Issue(s) they said they’d lobby about: Any legislation concerning medical device manufacturing or medical technology; specifically Medicare policy affecting reimbursement rates for medical devices and clinical trial policy. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate